GBIO
NASDAQGeneration Bio Co.
Price$5.37+0.09 (+1.80%)
2025-11-032026-02-06
News · 26 weeks500%
2025-12-142026-06-07
Mix090d
No activity.
Latest news
25 items- SECSEC Form 15-12G filed by Generation Bio Co.15-12G - Generation Bio Co. (0001733294) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Generation Bio Co.SCHEDULE 13G/A - Generation Bio Co. (0001733294) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Generation Bio Co.SCHEDULE 13G/A - Generation Bio Co. (0001733294) (Subject)
- SECSEC Form EFFECT filed by Generation Bio Co.EFFECT - Generation Bio Co. (0001733294) (Filer)
- INSIDERSEC Form 4 filed by Large owner Atlas Venture Fund X, L.P.4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Stehman-Breen Catherine closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERSEC Form 4 filed by Director Rhodes Jason P4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Rowland Charles A Jr closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Quinn Anthony G. closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Nicholson Donald William closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Mcdonough Geoff closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERSEC Form 4 filed by Director Jonas Jeffrey M4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERINTERIM CEO AND PRESIDENT Howze Yalonda closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Conway Kevin John closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Cooper Ronald Harold Wilfred closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Christensen Gustav closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- INSIDERDirector Appelhans Dannielle closing all direct ownership in the company (SEC Form 4)4 - Generation Bio Co. (0001733294) (Issuer)
- SECSEC Form POS AM filed by Generation Bio Co.POS AM - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
- SECSEC Form S-8 POS filed by Generation Bio Co.S-8 POS - Generation Bio Co. (0001733294) (Filer)
GBIO FAQ
7 questionsWhat does Generation Bio Co. do?
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.Where does GBIO stock trade?
Generation Bio Co. (GBIO) is listed on NASDAQ.What sector and industry is GBIO in?
Generation Bio Co. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Generation Bio Co. go public?
Generation Bio Co. (GBIO) completed its IPO in 2020.What are analysts saying about GBIO?
Generation Bio Co. has had 8 recent analyst actions on file. The most recent action was from Wedbush: Outperform with a $550.00 price target on 2025-12-16.What companies are similar to GBIO?
Notable peers in the same industry include GRPH (Graphite Bio Inc.), GRTS (Gritstone bio Inc.), PRVB (Provention Bio Inc.), SESN (Sesen Bio Inc.), TIL (Instil Bio Inc.). Compare GBIO side-by-side with any of them on Quantisnow.How can I track GBIO on Quantisnow?
Quantisnow aggregates Generation Bio Co.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GBIO to receive live email and push alerts on every new disclosure.